Steve Becker joins Broken String Biosciences as Chief Commercial Officer Steve Becker joins Broken String Biosciences as Chief Commercial Officer Steve's will help to push the company's INDUCE-seq commercialisation strategy forward Metrion Biosciences appoints Dr Chris Mathes as Chief Commercial Officer Metrion Biosciences appoints Dr Chris Mathes as Chief Commercial Officer Chris' appointment will assist the company in making its commercial growth plans a reality Optibrium appoints James Halle as Chief Commercial Officer Optibrium appoints James Halle as Chief Commercial Officer James will assist the company in commercialising StarDrop, Cerella and Semeta, the company's proprietary drug development platforms Cherwell appoints Andy Charteris as new Director of Operations Cherwell appoints Andy Charteris as new Director of Operations Andy will assist Cherwell in its plans to acceleration its growth in the cleanroom space Vivet Therapeutics’ Dr Gloria Gonzalez-Aseguinolaza receives the Rosalind Franklin Society Special Award in Science Vivet Therapeutics’ Dr Gloria Gonzalez-Aseguinolaza receives the Rosalind Franklin Society Special Award in Science The award was appointed to Dr Gloria Gonzalez-Aseguinolaza for her work in advancing cell and gene therapies Mogrify appoints Dr Jonathan Appleby as Chief Scientific Officer Mogrify appoints Dr Jonathan Appleby as Chief Scientific Officer Dr Appleby has extensive experience in the development and commercialisation of both conventional and advanced therapeutics Cellular Origins appoints Geoffrey Hodge as Non-Executive Director Cellular Origins appoints Geoffrey Hodge as Non-Executive Director Geoff will contribute to the company's commercial growth efforts while also shaping the future direction of Cellular Origins Quell Therapeutics Appoints Experienced Biopharma Leader Luke Beshar as Independent Chair of its Board of Directors Quell Therapeutics Appoints Experienced Biopharma Leader Luke Beshar as Independent Chair of its Board of Directors Luke brings more than 35 years of experience to the role, and has been non-executive director of a range of large biopharmaceutical companies etherna appoints Antonin de Fougerolles as new Chairperson etherna appoints Antonin de Fougerolles as new Chairperson Tony has extensive experience in the development of novel therapeutic modalities, such as RNAis and modified mRNAs for vaccinations Selkirk Pharma appoints Colleen Dixon as CEO Selkirk Pharma appoints Colleen Dixon as CEO Colleen has more than 30 years of experience in the pharmaceutical industry, and will succeed Patrick Haffey Newcells Biotech appoints Emile Shaffu as Director of Sales Newcells Biotech appoints Emile Shaffu as Director of Sales Emile will work with Newcells to expand its global presence, as well as boost its customer service capabilities H.E.L Group appoints Yih-Shing Duh as Chief Scientific Advisor H.E.L Group appoints Yih-Shing Duh as Chief Scientific Advisor Prof. Duh will continue to assist H.E.L Group in developing its battery calorimeters and lithium ion battery testing protocols Lonza appoints Wolfgang Wienand as the group’s CEO Lonza appoints Wolfgang Wienand as the group’s CEO Wolfgang will lead Lonza as the CDMO continues to push its growth and customer satisfaction Marchesini Group appoints President Maurizio Marchesini as CEO Marchesini Group appoints President Maurizio Marchesini as CEO President Marchesini will focus on investing in technological advances in pharmaceutical manufacturing, as well as globalisation for the group Asymchem appoints Dr Cheng Yi Chen as CTO of Small Molecules Asymchem appoints Dr Cheng Yi Chen as CTO of Small Molecules He will support the group's small molecule sales and offer technical guidance to laboratories and pilot production sites across Europe CN Bio appoints Lydia Seymour as VP of People and Culture CN Bio appoints Lydia Seymour as VP of People and Culture Lydia will work to enhance the company's workplace culture, whilst also supporting the career development and general wellbeing of employees